Inflexion in 2.8x pharma exit
The UK-based firm has agreed to sell Phlexglobal to Bridgepoint Development Capital for £42m
The UK-based firm has agreed to sell Phlexglobal to Bridgepoint Development Capital for £42m
Copyright PEI Media
Not for publication, email or dissemination